Ferrari F, Giuliani D
Department of Biomedical Sciences, University of Modena, Italy.
Pharmacol Res. 1995 May;31(5):261-7. doi: 10.1016/1043-6618(95)80030-1.
The effects of the selective D2 DA receptor antagonist, (-)eticlopride, a drug belonging to the benzamide class, were investigated on the D2 DA agonist SND 919- and CQP 201-403-induced stereotyped behaviour and on CQP 201-403-induced shaking, in rats, and on isolation-induced aggression, in mice. (-)Eticlopride was also tested over a wide dose range (5-1200 micrograms kg-1, s.c.) for sedative and cataleptic activity, in rats. For comparison, some experiments were performed with (-)sulpiride (10 and 40 mg kg-1, s.c.) The data obtained show that (-)eticlopride differs from (-)sulpiride and potentially modifies animal behaviour, whether spontaneous or induced; moreover, they suggest a potential clinical use for this neuroleptic in the management of psychotic states.
研究了苯甲酰胺类药物选择性D2多巴胺受体拮抗剂(-)依托必利对大鼠D2多巴胺激动剂SND 919和CQP 201 - 403诱导的刻板行为以及CQP 201 - 403诱导的颤抖,以及对小鼠隔离诱导攻击行为的影响。还在大鼠中对(-)依托必利在广泛剂量范围(5 - 1200微克/千克,皮下注射)进行了镇静和僵住活性测试。为作比较,用(-)舒必利(10和40毫克/千克,皮下注射)进行了一些实验。所得数据表明,(-)依托必利与(-)舒必利不同,可能改变动物的自发或诱导行为;此外,这些数据提示该抗精神病药物在精神状态管理方面具有潜在临床用途。